Last reviewed · How we verify
NCT05957068: BREXINT
Breast Cancer Exercise Intervention Study
NA trial testing Exercise Programme in Early-stage Breast Cancer in 2,156 participants. Currently enrolling.
31 May 2028
Quick facts
| Lead sponsor | National Cancer Centre, Singapore |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2,156 |
| Start date | 1 July 2023 |
| Primary completion | 31 May 2028 |
| Estimated completion | 31 May 2033 |
| Sites | 3 locations across Singapore |
Drugs / interventions tested
- Exercise Programme
- Control
Conditions studied
- Early-stage Breast Cancer — all drugs for Early-stage Breast Cancer →
- Locally Advanced Breast Cancer — all drugs for Locally Advanced Breast Cancer →
Sponsor
National Cancer Centre, Singapore
Who can join
Adults 21 to 99, female only, with Early-stage Breast Cancer or Locally Advanced Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a 24-week exercise programme consisting of aerobic exercise and muscle strength training, 3 sessions per week. The first 9 sessions are supervised by physiotherapists in person, followed by 63 sessions monitored remotely (video) or supervised by trainers at ActiveSG (Sport Singapore) gyms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05957068
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise Programme
Trials testing the same drug.
- NCT05738720 — Effect of Home Based Pulmonary Rehabilitation on Exacerbation and Hospital Admission in Severe COPD · NA · recruiting
- NCT07060339 — Effect of Nonpharmacological Methods on The Active Phase Of Labour · NA · completed
- NCT03848000 — Examination of Whether an Exercise Programme Reduces Alcohol Consumption Among Alcohol-Dependent Adults · NA · completed
- NCT05869630 — Exercise on microRNA in Osteoarthritis · NA · completed
- NCT03064308 — The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery · NA · completed
Other recruiting trials for Early-stage Breast Cancer
Currently open trials in the same condition.
- NCT06215469 — Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) · NA · recruiting
- NCT06144944 — Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer · Phase 3 · active not recruiting
- NCT06001762 — TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer · Phase 2 · active not recruiting
- NCT06035016 — Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer · recruiting
- NCT05760612 — Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breas · Phase 3 · recruiting
Other National Cancer Centre, Singapore trials
Trials by the same sponsor.
- NCT07428356 — Histotripsy for Ablation of Liver Tumours in Asia · NA · recruiting
- NCT07428655 — Acceptability and Feasibility of PSC Model of Serious Illness Communication · NA · active not recruiting
- NCT07116161 — Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore · NA · recruiting
- NCT06977360 — Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solutio · NA · recruiting
- NCT06766058 — Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05957068 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Centre, Singapore
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05957068.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing